Visus Presbyopia Drop Gets FDA IND OK

April 8, 2021

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

Print

MORE NEWS

January 8, 2024
The Ultimate Guide to Presbyopia Drops
>
Learn more about our latest developments

Visus Therapeutics, Inc.
2 Nickerson St. Ste 101
Seattle, WA 98109

© VISUS THERAPEUTICS 2021 ALL RIGHTS RESERVED
VISUS THERAPEUTICS and BRIMOCHOL are trademarks of Visus Therapeutics, Inc.